---
schema_version: "secwatch.filing_event.v1"
accession: "0001438133-23-000179"
form_type: "8-K"
ticker: "TNDM"
cik: "0001438133"
company_name: "TANDEM DIABETES CARE INC"
filed_at: "2023-08-18T23:59:59+00:00"
generated_at: "2026-06-11T06:53:41.720247+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Tandem CCO Brian Hansen resigns, to stay on leave through June 2024

## Summary
- Brian Hansen resigns as EVP & CCO effective Dec 31, 2023; remains employed through June 28, 2024 on paid administrative leave.
- Will receive base salary through separation date, 2023 corporate bonus, and continued vesting of stock options and RSUs through June 28, 2024.
- Company will pay COBRA premiums for up to six months after Dec 31, 2023 (through June 30, 2024).
- Agreement includes 12-month non-solicitation of employees and a standard release of claims; full terms in Exhibit 10.1.

## SEC filing metadata
- accession: 0001438133-23-000179
- form_type: 8-K
- ticker: TNDM
- cik: 0001438133
- company_name: TANDEM DIABETES CARE INC
- filed_at: 2023-08-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438133/000143813323000179/0001438133-23-000179-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438133/000143813323000179/tndm-20230817.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001438133-23-000179
- JSON: https://secwatch.observer/filing/0001438133-23-000179.json
- Plain text: https://secwatch.observer/filing/0001438133-23-000179.txt

## Key facts
- Executive change
  Brian B. Hansen resigned as Executive Vice President and Chief Commercial Officer at TANDEM DIABETES CARE INC.
  - Action: resigned
  - Role: Executive Vice President and Chief Commercial Officer
  source text: On August 17, 2023, Brian B. Hansen, Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the Company), notified the Company of his decision to resign from his role as Executive Vice President and Chief Commercial Officer, effective December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438133/000143813323000179/0001438133-23-000179-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.